Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −324,724−100.0% | Sold out | Holders |
| Q2 2022 | 324,724 | $19.4M | 0.1% | +10,980+3.5% | Added | Holders |
| Q1 2022 | 313,744 | $22.8M | 0.1% | +630.0% | Added | Holders |
| Q4 2021 | 313,681 | $26.4M | 0.1% | −116,225−27.0% | Reduced | Holders |
| Q3 2021 | 429,906 | $38.8M | 0.1% | +65,097+17.8% | Added | Holders |
| Q2 2021 | 364,809 | $34.8M | 0.1% | −13,017−3.4% | Reduced | Holders |
| Q1 2021 | 377,826 | $43.0M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.